Related Experiment Videos
Human cancer cell lines growth inhibition by GTn oligodeoxyribonucleotides recognizing single-stranded DNA-binding
B Scaggiante1, C Morassutti, B Dapas
1Department of Biomedical Sciences and Technologies, University of Udine, Italy.
Abstract:
Oligonucleotides can specifically target not only nucleic acids but also proteins. Some proteins recognizing oligonucleotides in a sequence-specific manner have been related to cancer transformation and progression. We have found that oligonucleotides composed by repeated and/or variable intervals of GTn with 1 < or = n < or = 7, are able to exert a specific and dose-dependent growth inhibition on human CCRF-CEM, CEM-VLB300, U937, Jurkat, H9 and HeLa tumor cell lines. In contrast, G-->C, G-->A, T-->C and T-->A base substituted control oligonucleotides do not significantly alter cellular growth. In all cell lines, a nuclear protein (molecular mass = 45+/-7 kDa), which specifically recognizes GTn, was identified. Our hypothesis is that the formation of the GTn-protein complex in human cancer cell lines may be involved in the growth inhibition effect. In fact, we found that the reduction or lack of cytotoxic effects by GTn in phorbol 12-myristate 13-acetate-treated CCRF-CEM cells and in normal human lymphocytes is paralleled by the simultaneous reduction or lack of GTn-protein complex. Oligonucleotides specifically 'quenching' intracellular protein activities by forming oligonucleotide-protein complexes may be of potential interest in the treatment of human tumors.
Insights
Specific GTn oligonucleotides inhibit cancer cell growth by forming complexes with a nuclear protein. This targeted approach shows potential for human tumor treatment.
Area of Science:
- Molecular Biology
- Cancer Research
- Oligonucleotide Therapeutics
Background:
- Oligonucleotides can target both nucleic acids and proteins.
- Certain proteins that recognize oligonucleotides are linked to cancer progression.
Purpose of the Study:
- To investigate the anti-cancer effects of GTn oligonucleotides.
- To identify the mechanism behind the observed growth inhibition.
Main Methods:
- Treatment of various human cancer cell lines (CCRF-CEM, CEM-VLB300, U937, Jurkat, H9, HeLa) with GTn oligonucleotides.
- Identification of nuclear proteins that specifically recognize GTn sequences.
- Analysis of GTn-protein complex formation and its correlation with cytotoxic effects.
Main Results:
- GTn oligonucleotides demonstrated specific, dose-dependent growth inhibition in multiple tumor cell lines.
- A nuclear protein (45+/-7 kDa) specifically recognizing GTn was identified in all tested cell lines.
- Reduced GTn-protein complex formation correlated with diminished cytotoxic effects in treated cells and normal lymphocytes.
Conclusions:
- GTn oligonucleotides inhibit cancer cell growth through specific interaction with a nuclear protein.
- The formation of GTn-protein complexes is implicated in the observed anti-tumor activity.
- Oligonucleotides targeting intracellular protein activities represent a potential strategy for human tumor therapy.